- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
The point-of-care (PoC) analyzers are intended for use in medical offices, clinics, hospitals, and laboratories to deliver prompt and precise results at a reasonable cost. By definition, PoC testing takes place in the patient's presence, allowing for frank communication between the patient and the practitioner.
The Global point of care analyzer market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The launch of Epithod AutoDx, a completely autonomous point-of-care (POC) analyzer that assesses a comprehensive profile of diabetes tests, is being jointly announced by Precision Diabetes, Inc. and DxGen Corp. Hemoglobin A1c (A1C), C-reactive protein, and urine albumin will be the first tests on the initial test menu; further diabetes tests will be introduced soon.
By incorporating Epithod AutoDx into the diabetes product portfolio, they are demonstrating commitment to providing healthcare professionals access to critical clinical diagnostics focused on early detection, prevention, and management of diabetes, prediabetes, and associated complications in point-of-care settings.
They anticipate having the most complete and user-friendly POC diabetes test solution available in the market as we continue to develop the menu for diabetic tests.
As the diabetes epidemic doesn't abate, the market for POC tests for diabetes keeps growing quickly. As the menu of diabetes tests continues to grow, The Epithod® AutoDx is well positioned to take the lead in this industry.
| Sl no | Topic |
| 1 | Market Segmentation |
| 2 | Scope of the report |
| 3 | Abbreviations |
| 4 | Research Methodology |
| 5 | Executive Summary |
| 6 | Introduction |
| 7 | Insights from Industry stakeholders |
| 8 | Cost breakdown of Product by sub-components and average profit margin |
| 9 | Disruptive innovation in the Industry |
| 10 | Technology trends in the Industry |
| 11 | Consumer trends in the industry |
| 12 | Recent Production Milestones |
| 13 | Component Manufacturing in US, EU and China |
| 14 | COVID-19 impact on overall market |
| 15 | COVID-19 impact on Production of components |
| 16 | COVID-19 impact on Point of sale |
| 17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
| 18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
| 19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
| 20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
| 21 | Product installation rate by OEM, 2023 |
| 22 | Incline/Decline in Average B-2-B selling price in past 5 years |
| 23 | Competition from substitute products |
| 24 | Gross margin and average profitability of suppliers |
| 25 | New product development in past 12 months |
| 26 | M&A in past 12 months |
| 27 | Growth strategy of leading players |
| 28 | Market share of vendors, 2023 |
| 29 | Company Profiles |
| 30 | Unmet needs and opportunity for new suppliers |
| 31 | Conclusion |
| 32 | Appendix |
© 2017-2025 Mobility Foresights Admin Pvt Ltd. All rights reserved.